|
|
|||
| |||||||||||||||||||||||||||||||||||||||
The introduction of neuraminidase inhibitors into clinical practice has led to new options for the prevention of influenza. As a group, the neuraminidase inhibitors are well tolerated and are active against both influenza A and B viral strains, and resistance
References
This article has been cited by other articles:
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |